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Independent functionConnexins, a family of transmembrane proteins, are components of both gap junction channels and
hemichannels, which mediate the exchange of ions and small molecules between adjacent cells, and
between the inside and outside of the cell, respectively. Substantial advancements have been made
in the comprehension of the role of gap junctions and hemichannels in coordinating cellular events.
In recent years, a plethora of studies demonstrate a role of connexin proteins in the regulation of
tissue homeostasis that occurs independently of their channel activities. This is shown in the con-
text of cell growth, adhesion, migration, apoptosis, and signaling. The major mechanisms of these
channel-independent activities still remain to be discovered. In this review, we provide an updated
overview on the current knowledge of gap junction- and hemichannel-independent functions of
connexins, in particular, their effects on tumorigenesis, neurogenesis and disease development.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Connexins are proteins which form both gap junctions and
hemichannels, which are ubiquitously found in both vertebrates
and invertebrates. Unapposed connexin hemichannels, which are
composed of six connexin molecules oligomerized into a cylinder,
are found at the plasmamembrane, where they allow the exchange
of small molecules (<1.2 kD) between the intracellular and extra-
cellular environments. As a newcomer of connexin-forming chan-
nels for over a decade, hemichannels are implicated in cellular
responses to various physiological conditions and metabolic and
oxidative stresses [1]. Gap junctions are hexameric channels
formed by two docked hemichannels from adjacent cells, which al-
low the transfer of small molecules between the adjoining cells.
Many physiological processes such as cell growth and cell death
are driven by the substances that are transferred through these
channels [2]. These molecules that pass through gap junctions in-
clude ions, second messengers, and small metabolites. Thus, gap
junctional intercellular communication (GJIC) is essential for the
maintenance and regulation of cell differentiation, tissue physiol-
ogy, and the normal functions of organs [3,4]. Since the molecules
that cross through hemichannels are similar to those which travel
through GJIC, hemichannel-dependent signaling is also seen as asigniﬁcant mediator of tissue homeostasis. Thus far, there are 20
different types of connexins which are known to exist in the mouse
and 21 types in humans, and the permeability and signaling prop-
erties of the individual gap junctions and hemichannels are deﬁned
by their speciﬁc connexins. It is well documented that GJIC is
important in mediating normal cell growth, differentiation, and
development. Non-coupling or non-communicating gap junctions
and hemichannels result in the disruption of normal homeostasis.
Among the various types of connexins, mutations or loss of func-
tional channels are implicated in many diseases and disorders such
as congenital deafness, skin disorders, cataracts and cancers [4,5].
Intriguingly, some disease-causing mutants of connexins form
functional channels [4] as those formed by wild-type connexins,
which implies channel-independent roles of connexins.
In recent years, more studies have focused on the gap junction-
and hemichannel-independent roles of connexins. Connexins are
reportedly able to inﬂuence cell adhesion, migration, and cell cycle
in a GJIC-independent manner [6–9]. A plethora of connexin-asso-
ciated proteins have been discovered, including cytoskeletal ele-
ments, enzymes, adhesion molecules, and signaling molecules.
These connexin-associated proteins are shown to regulate a num-
ber of mechanisms involved in both channel-dependent and
independent functions by connexins [8–10]. Additionally, GJIC
independent involvement of connexin-associated intercellular
adhesion has also been presented [7]. We previously provided an
overview of the gap junction-independent functions of connexins
on cell growth, differentiation and tumorigenicity [6]. Here,
we provide an updated summary on the growing list of
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role of connexins in cell growth, migration, apoptosis, signaling
and development. Furthermore, we discuss the impact of dysregu-
lated connexins on tumorigenesis and disease development.
2. Gap junction-independent functions of connexins on
tumorigenic cell growth, migration, and apoptosis
Loewenstein and Kanno [11] ﬁrst established evidence that liver
cancer cells were different from normal liver cells in that they
lacked intercellular communication. Since then, there has been a
surge of studies dedicated to discovering the role of gap junctions
and connexins in tumor progression [5,12]. Reduced expression of
connexins and GJIC has been shown in many tumor types, and con-
nexins have been recognized as tumor suppressors. Clinical studies
show that deﬁcient or abnormal connexins are frequently found in
tumor tissues and cell lines, such as breast cancer, prostate cancer,
lung cancer, and many other cancers. Connexins are considered to
be tumor suppressors through the transmission of signaling mole-
cules that regulate cell proliferation, migration, and apoptosis.
However, recently, more studies acknowledge that these effects
on cancer behavior may depend on the connexin protein itself,
rather than on the cell–cell coupling [13]. Although there remains
experimental evidence regarding the involvement of gap junctions
in controlling cell growth, migration, and tumorigenesis, there is
mounting evidence supporting the position of GJIC-independent
roles of connexins in cancer cell growth and progression (see
Table 1 for a summary).
Many studies suggest the signiﬁcant inhibitory inﬂuence of con-
nexins on the control of tumor cell growth and migration of many
cancer cell types through a non-GJIC route. These effects were ob-
served with Cx26 in breast cancer [14]. The role of Cx26 in MDA-
MB-435 breast cancer migration and invasion was revealed by
using three Cx26 mutants: one expressing GJIC-competent Cx26,
a GJIC-incompetent Cx26, and a Golgi apparatus-localized dis-
ease-linked Cx26 mutant. This method was used to determineTable 1
Summary of the published studies of gap junction-independent functions of connexins on
References Cell Connexi
Kalra et al. [14] MDA-MB-435 cells Cx26
Xu et al. [15] NSCLC patient samples and LH7 cells Cx43
Ionta et al. [16] HTC and BRL3A cells Cx43
Li et al. [17] HuH7 and Li-7 cells Cx32
Lamiche et al. [18] LNCaP and PC3 cells Cx43
Zucker et al. [19] WM793B and 1205Lu cells Cx43
Zhang et al. [20] BEAS-2B, WI-38, Calu-3, A549, NCI-H1299,
NCI-H460, and NCI-H226 cells
Cx31.1
McLachlan et al. [21] MDA-MB-231 and MDA-MB-435 cells Cx26
Cx43
Fukushima et al. [22] PC3 and LNCaP cells Cx43
Mauro et al. [23] JKT-1 cells Cx43
Sun et al. [24] BxPC-3, SW1990, PaTu8988, PANC-1, AsPC-
1 and CFPAC-1 cells
Cx43
Sato et al. [25] A549 cells Cx32
Fujimoto et al. [32] Caki-1 cells Cx32
Langlois et al. [34] REK, Hs 456.Sk, and SCC-13 cells Cx43
Herrero-Gonzalez et al. [35] C6 cells Cx43
Crespin et al. [37] LN18 and HEK293 cells Cx43
Gellhaus et al. [38] 293T cells Cx43
Johnstone et al. [39] HeLa and HFF cells Cx43whether the expression of functional and GJIC-incompetent sub-
types of Cx26 could change the tumorigenic characteristics of these
cells. All three variants inhibited anchorage-independent growth
and signiﬁcantly reduced cell migration. Furthermore, expression
of all Cx26 variants exhibited decreased b1 integrin level and
MMP-9 activity, and increased TIMP-1 activity. This data suggests
that Cx26 expression is independent of GJIC communication in
reverting the tumorigenic properties of MDA-MB-435 cells. In lung
cancer, Xu et al. [15] demonstrated the reduction of both Cx43 and
E-cadherin expression in advanced non-small cell lung cancer
(NSCLC) patient samples. After overexpressing Cx43 in the lung
cancer cell line LH7, E-cadherin expression was found to be con-
currently upregulated. Additionally, Cx43 overexpression was cor-
related with the inhibition of proliferation and cell cycle transition.
This effect appears to be independent of GJIC, as the Cx43 was
localized in the cytosol rather than at the cell surface. These cell
proliferation inhibitory effects of Cx43 are also shown to be signif-
icant in the progression of liver cancer. Ionta et al. [16] found that
the introduction of exogenous Cx43 expression into rat hepatocel-
lular carcinoma (HCC) cells causes a decrease in cell growth as well
as a reversion of the transformed phenotype. These effects were
independent of GJIC, as there was no evidence of a difference in
GJIC capacity when comparing the transfected cells versus control
cells as assessed by dye transfer with Lucifer Yellow. However,
there were changes in the phosphorylation pattern of Cx43, which
could affect its ability to oligomerize and transport to the plasma
membrane. These studies demonstrate how various connexins
may impede the growth and migration of breast, lung, and liver
cancer cells.
Several studies have shown that connexins are involved differ-
ently at distinct stages of tumor progression. At the primary tumor
level, many connexins exhibit decreased expression or impaired
trafﬁcking, as we discussed in the previous examples. However,
as the neoplastic lesions progress to more invasive and undifferen-
tiated stages, the connexins can become upregulated [5]. In HCC,
increased Cx32 protein enhanced its progression through increasedtumorigenic cell growth, migration, apoptosis, and cell signaling.
n GJIC-independent functions
Inhibits anchorage-independent growth and cell migration. Decreases b1
integrin and MMP-9 activity. Increases TIMP-1 activity
Inhibits proliferation and cell cycle transition
Decreases cell growth and reverts the transformed phenotype
Increases cell proliferation, migration, and invasion
Increases migration in LNCaP cells
Decreases proliferation, adhesion, and invasion in PC3 cells
Decreases anchorage-independent growth and increases invasion
Decreases cell proliferation, delays cell cycle at G1 phase, decreases
migration and invasion
Decreases anchorage-independent growth and migration. Reverses EMT
Inhibits endothelial cell tubulogenesis and migration, reducing tumor
angiogenesis
In combination with Docetaxel, inhibits cell growth and induces apoptosis
In combination with Griseofulvin, induces apoptosis
Increase apoptosis and inhibit cell growth
In combination with Vinorelbine, induces apoptosis and decreases cell
proliferation
Induces apoptosis and decreases cell proliferation
Cells with reduced Cx43 expression have increased EMT and invasive
features
Inhibits progression to S phase in the cell cycle, decreases rate of
proliferation. Diminishes c-Src activity
Inhibits cell growth and increases cell migration, and induces actin
cytoskeleton reorganization by C-terminal tail of Cx43
The C-terminal tail of Cx43 interacts with CCN3 and reduces the growth of
293T cells
Increased Cx43 expression delays mitotic durations and reduces cell
proliferation
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[17]. By utilizing an inducible expression system of Cx32 in a hu-
man HCC cell line, it was discovered that despite a dramatic in-
crease in Cx32 expression, none of the cells were coupled by the
dye, and Cx32 protein was retained primarily in the Golgi appara-
tus. Additionally, the induced expression of Cx32 caused a signiﬁ-
cant increase in proliferation rate as well as migration and
invasion. Furthermore, an in vivo model demonstrated increased
metastatic lesions in mice with induced Cx32 expression cells. A
report by Lamiche et al. [18] showed that the localization and func-
tionality of Cx43 in prostate cancer cells may govern its ability to
metastasize to bone. Two different prostate cancer cell lines were
used. In LNCaP cell lines, Cx43 was functional and localized at
the plasma membrane, which allowed the cells to become highly
aggressive as well as creating more osteolytic metastases in bone
xenografts. In PC3 cells, Cx43 was localized in the cytoplasm and
nonfunctional, leading to a reduction in proliferation, adhesion,
and invasion. Thus, the differential effects of Cx43 channels on
prostate cancer cells are likely to be primarily caused by the types
of prostate cancer cells used. The dual role of connexins in cancer
behavior is also investigated in metastatic melanoma behavior,
where Zucker et al. [19] examined the effects of a third transmem-
brane domain mutation (T154A) in Cx43, resulting in a dominant
negative Cx43 mutant in which the channels remained closed.
The dye preloading assay with calcein-AM and DiI demonstrated
that pre-metastatic WM793B and metastatic 1205Lu melanoma
cells transfected with the T154A Cx43 mutant were deﬁcient in
channel coupling. Transfection of the metastatic 1205Lu melanoma
cells with T154A reduced the anchorage-independent growth.
Additionally, the 1205Lu–T154A Cx43 mutants exhibited increased
invasion. These effects were not due to the lack of communication
since the opposite effects were not observed with wild type Cx43.
Despite these studies showing the stimulatory role of connexins on
invasive cancers, other studies report otherwise. Zhang et al. [20]
found that Cx31.1 is downregulated in ﬁve NSCLC cell lines as com-
pared to normal human lung epithelial cells, and the expression is
inversely related to the metastatic potential. After overexpressing
Cx31.1 in the NSCLC cell line H1299, they found that Cx31.1 does
not form functional gap junction channels and is localized intracel-
lularly. Furthermore, the cell proliferation was decreased, cell cycle
was delayed at the G1 phase, anchorage-independent growth was
inhibited, and cell migration and invasion were suppressed. Addi-
tionally, xenografts of Cx31.1-overexpressing cells into nude mice
had reduced tumorigenicity compared to control cells. They con-
cluded that Cx31.1 may act as a tumor suppressor in NSCLC cell
lines by reversing the epithelial to mesenchymal transition (EMT)
process. These studies provide conﬂicting evidence of the precise
role of connexins in regulating cancer growth and migration in a
GJIC-independent fashion. Many of these studies suggest that the
expression of connexins, but not the degree of channel formation,
relates to tumor progression.
GJIC-independent connexin effects on tumorigenesis extend be-
yond proliferation and migration into other hallmarks of cancer,
including angiogenesis and apoptosis. Cx26 and Cx43 further reg-
ulate other tumorigenic properties of MDA-MB-231 breast cancer
cells, such as angiogenesis and EMT, in a GJIC-independent way
[21]. The overexpression of either Cx26 or Cx43 reduced anchor-
age-independent growth and induced partial re-differentiation of
MDA-MB-231 three-dimensional organoids. The connexins did
not assemble into gap junctions at the plasma membrane, nor
did they establish GJIC as assessed by dye transfer using ﬂuores-
cence recovery after photobleaching (FRAP). It was also discovered
that connexin overexpression caused a reduction in cell migration
and promoted a reversal of EMT. Additionally, connexin expression
could regulate the expression of molecules important in angiogen-
esis, such as monocyte chemotactic protein-1 (MCP-1) and IL-6.This study provided the ﬁrst evidence of the role of connexins in
regulating angiogenesis in breast tumors.
There is much evidence pointing to the additive effect of con-
nexins in combination with other chemotherapeutic agents to reg-
ulate cancer apoptosis. The combination of Docetaxel (DTX) with
the expression of the Cx43 gene was discovered to be the optimal
treatment for advanced hormone refractory prostate cancer [22].
Transfection of the Cx43 gene by itself into PC3 cells did not inhibit
tumor growth or increase GJIC assessed by calcein-AM and DiI dye
transfer, but in combination with DTX, it inhibited cell growth and
induced apoptosis. This was achieved through the downregulation
of Bcl-2 expression and activation of the apoptosis pathway. The
combinatorial use of Cx43 and DTX also signiﬁcantly inhibited
the growth of PC3 tumor xenografts. These results indicate that
Cx43 is effective in enhancing the cytotoxicity of DTX by downreg-
ulating Bcl-2. Cx43 also aids in the apoptotic effects of germ cell tu-
mors in response to Griseofulvin, an antifungal antimitotic drug,
through translocation from the cytoplasm to the nucleus [23].
Cx43 immunoreactive signal was mainly found distributed
throughout the cytoplasm of tumoral germ cells and there was
no coupling found between adjacent cells. When viewed with
three dimensional, high-resolution deconvolution microscopy,
the cells treated with Griseofulvin had many Cx43 spots in the per-
inuclear region. Cx43 contains a nuclear targeting sequence in its
C-terminal domain that is involved in the control of cell death gene
expression, which explains why Cx43 is required for Griseofulvin
to activate the caspase and apoptosis pathway. In pancreatic can-
cer, Cx43 is also shown to mediate apoptosis regulation [24].
Cx43 translocates to the mitochondria, where it interacts with
Bax through the amino acid residues 241–382 and initiates the
mitochondrial apoptotic pathway. When 18b-glycyrrhetinic acid
(b-GA) was added to inhibit GJIC, Cx43 was still able to inhibit
the growth and induce apoptosis in the BxPC-3 pancreatic cancer
cells. Additionally, a dominant-negative Cx43 mutant (Cx43N)
with deletion of amino acids 130–136, which inhibits Cx43-medi-
ated GJIC, also preserved the tumor-suppressive activity. Cx32 is
another connexin demonstrated to be effective in combinatorial
therapy, as shown in lung adenocarcinoma, where it ampliﬁes
the cytotoxic effects of the chemotherapeutic drug Vinorelbine
(VBN) [25]. This was shown to be partially due to GJIC effects,
and partially GJIC-independent. When a gap junction inhibitor
was added, there was a partial abrogation of VBN-induced cytotox-
icity in A549 transfected with Cx32, but no effect was seen on con-
trol cells treated with VBN. These ﬁndings reveal the vital role of
connexins in cancer progression and how they may be used in
combination with chemotherapeutic drugs to prevent the advance-
ment of various cancers. Many studies still report conﬂicting evi-
dence regarding the exact role of connexins as either tumor
suppressors or tumor promoters, and whether these actions are
through the exchange of molecules through its gap junctions and
hemichannels, or whether it is due to a GJIC-independent mecha-
nism, especially in the more invasive and metastatic cancers. As
seen in Fig. 1, evidence of the non-GJIC tumor suppressive effects
of connexins seem to outweigh those reﬂecting the tumor pro-
moter effects. Most notably, they demonstrate that connexins are
a key player involved in inhibiting the progression of breast, pros-
tate, and lung primary cancers. Furthermore, there are increasing
conﬁrmations from studies suggesting that many of the known
connexin tumor suppressive effects are through GJIC-independent
mechanisms [7–10,6].
3. Gap junction-independent functions of connexins on
tumorigenic cell cycle and signaling
Several studies from previous years have provided evidence of
how connexin proteins inﬂuence cell growth independently of
Connexins
Non-GJIC Tumor 
Suppressor Eﬀects
Non-GJIC Tumor 
Promoter Eﬀects
• Decreases tumor growth 
[14, 15, 16, 18, 19, 20, 21, 
22, 24, 25, 32, 35, 37, 38, 
39]
• Delays cell cycle transion 
[15, 20, 35, 39]
• Decreases tumor migraon 
[14, 16, 18, 20, 21, 34]
• Increases apoptosis [22, 
23, 24, 25, 32]
• Reverses EMT [21, 34]
• Increases tumor migraon 
[18, 19, 37]
Fig. 1. Non-GJIC tumor promoting and tumor suppressing effects of connexins. The non-GJIC effects of connexins on tumor behavior can be separated into tumor promoter
and tumor suppresser categories. These effects may further be subcategorized into inﬂuences on the tumor growth, migration, cell cycle, apoptosis, and EMT.
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Fig. 2. Interaction between the connexin 43 C-terminal tail and signaling factors.
The C-terminal tail of Cx43 interacts with many signaling factors and regulators of
cancer behavior. Phosphorylation of tyrosine 247 and 265 of the C-terminal tail
inhibits c-Src activity and decreases proliferation of glioma cells [35,36] (A).
Phosphorylation of serines 255, 262, 279, and 282 of the C-terminal tail by MAPK
increases proliferation of vascular smooth muscle cells [52] (B). Phosphorylation of
serine 262 of the CT by PKC inhibits DNA synthesis in HEK293 cells [41] and leads to
cardiac ischemic injury resistance [48] (C). Interaction of the CT with Cav-1 reduces
human keratinocyte skin tumor transformation and invasion [34] (D). Interaction of
the CT amino acids 257–382 with CCN3 decreases growth of 293T human
embryonic kidney epithelial cells [38] (E).
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pact on cell cycle and signaling [10]. This is due to the inﬂuence
of connexin proteins on the production and activity of many cell
cycle regulators, such as p27Kip1, cyclin A, cyclin D1, cyclin D2,
ERK1/2, Src, and FGF1, just to name a few [26–31]. For example,
the C-terminal tail of Cx43 (243–382 aa), which lacks intrinsic
gap junction activity, has been shown to be just as effective as
the full protein in suppressing neuroblastoma progression through
its effects on signaling molecules such as Src [8]. In a similar vein,
Fujimoto et al. [32] demonstrate that the inactivation of Src in-
creases the tumor suppressive effect of Cx32 in renal cancer cells.
The authors previously demonstrated that Src is an important
determinant in the malignancy of renal cell carcinoma [33]. In
the current study, the combination of a Src inhibitor and Cx32
was effective in regulating the growth and survival by inducing a
cytotoxic effect on renal cancer cells [32]. A more recent example
of the inﬂuence of connexins on tumorigenic cell signaling and cell
cycle is shown by Langlois et al., [34] who examined the effects of
Cx43 interaction with the skin tumor suppressor caveolin-1 (Cav-
1) in rat epidermal keratinocytes (REK). REK cells with reduced
Cx43 expression exhibited increased EMT as well as more invasive
features than the control cells. On the other hand, Cx43 overex-
pression caused an inhibition of the invasive properties. Blocking
the gap junctions with carbenoxolone did not affect the invasive
behavior; thus, GJIC was not involved. Furthermore, Cx43 was able
to colocalize with Cav-1 through its C-terminal domain, and this
interaction between the Cx43 C-terminal tail and Cav-1 played a
crucial protective role in keratinocyte transformation and invasion
(Fig. 2). This was also exempliﬁed in vivo, where the colocalization
of Cx43 and Cav-1 was reduced in human keratinocyte skin tumors
such as epidermal squamous cell carcinoma cells, suggesting a pro-
tective role against keratinocyte transformation by the interaction
between Cx43 and Cav-1. Further evidence of Cx43’s effects on cell
cycle is exempliﬁed in C6 glioma cells, where the restoration of
Cx43 inhibits their progression to the S phase of the cell cycle, ow-
ing in part to a reduction of cyclin E expression, which decreases
the rate of proliferation [35]. c-Src is known to phosphorylate
Cx43 from previous studies [36], and interestingly, it is shown here
that the restoration of Cx43 expression in glioma cells diminishes
c-Src activity, exhibited by a decrease in the active form (Y416 c-
Src) and an increase in the inactive form (Y527 c-Src). Additionally,a Cx43 mutant lacking its c-Src phosphorylation sites, Tyr247 and
Tyr 265, was not able to inhibit the c-Src activity and did not exhi-
bit decreased glioma proliferation. This suggests that the Tyr247
and Tyr 265 residues on the C-terminal tail of Cx43 are involved
in the anti-proliferative effects (Fig. 2). This data suggests that
Cx43 and c-Src are mutually regulated by a reciprocal activation/
inactivation loop via protein phosphorylation. Connexins have also
been implicated in the regulation of migration and proliferation
through its interactions with the actin cytoskeleton. This study
1190 J.Z. Zhou, J.X. Jiang / FEBS Letters 588 (2014) 1186–1192examined the effects of Cx43 in mediating the regulation of the ac-
tin cytoskeleton of human glioma cells [37]. The authors designed
two truncated constructs of Cx43: one lacking the C-terminal tail
and one lacking the entire transmembrane domain. It was discov-
ered that there was a similar reduction in the proliferation of gli-
oma cells regardless of whether the truncated versions or full
length version of Cx43 were used. Truncated Cx43 does not alter
GJIC, which was analyzed by dye transfer with calcein-AM. Addi-
tionally, the presence of a Cx43 C-terminal domain is sufﬁcient
to promote migration of glioma cells. The use of time-lapse imag-
ing showed that the C-terminus is associated with a lamellipodia-
type migration, suggesting that Cx43 signaling is involved in the
regulation of the actin cytoskeleton. Gellhaus et al. [38] established
a link between Cx43 and the growth regulator protein CCN3, which
is involved in the anti-proliferative activity of neuroblastoma, gli-
oma, and chronic myeloid leukemia. FRET analysis and co-immu-
noprecipitation were used to establish an interaction between
CCN3 and the C-terminus of Cx43 in human embryonic kidney epi-
thelial (293T) cells (Fig. 2). Several variants of Cx43 with amino
acid deletions were generated, and the interaction of the Cx43 vari-
ants with CCN3 was analyzed using FRET analysis. A 3D model of
the CCN3/Cx43 interaction complex was constructed, and through
co-immunoprecipitation, CCN3 was determined to speciﬁcally
bind to the C-terminus of Cx43 in the 257–382 aa region. The abil-
ity of Cx43 to reduce the growth of 293T cells was necessitated by
its binding with CCN3, leading to an increase in endogenous CCN3.
The signaling cascade after this binding to regulate proliferation
properties remains unknown. Because the truncated Cx43 variants
were still able to form functional channels, it is unlikely that GJIC is
responsible for the effects on proliferation. Thus, the reduction in
cell proliferation is caused by the direct interaction of CCN3 with
the C-terminus of Cx43, leading to an increase in CCN3 expression.
Johnstone et al. [39] studied the effects of Cx43 expression levels
on the regulation of cell cycle in HeLa cells transfected with Cx43
and primary human foreskin ﬁbroblasts (HFF), which express
Cx43 predominantly. 18-a-Glycyrrhetinic acid (GA) was used to
reduce GJIC but not affect Cx43 expression, and sodium butyrate
(NaBu) or anti-arrhythmic peptide (AAP10) were used to enhance
Cx43 expression in the cells. Using time-lapse microscopy, it was
discovered that the increase in Cx43 expression levels delayed mi-
totic durations, which corresponded with an accumulation of cells
in the G1 phase, leading to a reduction in cell proliferation. This
was linked to the increased expression of p21waf1/cip1, which is a
cell cycle inhibitor. These effects were independent of Cx43 chan-
nel function, which was determined by microinjection with Alexa
594 dye. Overall, it is suggested that the upregulation of Cx43
expression delays the rate of cell cycle traverse through the delay
of G1, thereby increasing time between mitotic cycles. The signiﬁ-
cant inﬂuence of connexins on the cell cycle and signaling regula-
tion of renal, skin, and neurological cancers is established by these
aforementioned studies.4. Gap junction-independent functions of connexins on nerve
cell growth, migration, apoptosis and development
Many connexins also inﬂuence the behavior of cells in neuro-
genesis. Cx32 is suggested to play a role in Neuregulin-1 (Nrg1)-
mediated proliferation which is not mediated by coupling [40].
The expression of Cx32 is upregulated in primary cultures of puri-
ﬁed Schwann cells (SCs) from newborn mouse sciatic nerve by
Glial growth factor 2 (GGF2), an isoform of Nrg1. However, SCs
from Cx32 knockout mice have a smaller mitogenic response to
GGF2. Additionally, there is no increase in electrical coupling be-
tween SCs following exposure to GGF2. Cx43 is known to inﬂuence
the migration of cells in the brain. For example, Cx43 plays animportant role in astrocytic wound closure and proliferation in re-
sponse to injury [41]. First, Cx43 expression was downregulated by
transfecting primary astrocyte cultures from cerebral cortices of
Sprague Dawley rats with a custom plasmid-generating microRNA
directed against Cx43 mRNA. The response of astrocytes to wound
healing was analyzed through a modiﬁed scratch wound assay,
where cells were ﬁxed and stained for Cx43 and GFAP at appropri-
ate times. The GJIC role was eliminated by using carbenoxolone, a
gap junction and hemichannel blocker, as analyzed by FRAP with a
calcein green-AM dye. As such, the wound closure rate was not af-
fected by the addition of carbenoxolone. This data implies the
inﬂuence of Cx43 in astrocyte response to injury that is separate
from the intercellular communication from gap junctions or re-
lease of molecules from hemichannels. Cx43 is also shown to con-
trol the directional migration and polarized cell movement of
cardiac neural crest cells (CNCs) [42]. CNCs were isolated from
Cx43 knockout mice and assessed for their polarity and migration.
The Cx43 knockout CNCs exhibited decreased adhesion as well as
directionality. Gap junction communication was assessed using
dye injections with carboxyﬂuorescein, and there were no associa-
tions found between the level of GJIC in these cells and changes in
motility or directionality. This suggests that Cx43 affects the
migration of CNCs through its signaling functions with other pro-
teins that regulate the cell motile behavior. Both Cx43 and Cx26
are able to inﬂuence the migration of newborn neurons to the cor-
tical plate in a fashion that does not depend on its channel func-
tions [43]. The connexins interact with the cellular cytoskeleton
to promote adhesion with the cortical cells, which enables migra-
tion. Both Cx26 and Cx43 were found to be expressed in migrating
neurons and along radial ﬁbers. The authors introduced short hair-
pin RNA (shRNA) constructs to knock down Cx26 and Cx43 in the
developing rat brain. The mutations signiﬁcantly disrupted the
neuronal migration and development of the neocortex. Rescue
experiments were performed in order to differentiate the exact
role of connexins in neuronal migration. To determine whether
functional channels are crucial to rescue the migration defect,
dominant-negative mutations were introduced to the tyrosine in
the third transmembrane domain of Cx26 and Cx43. These mutants
are able to make adhesions but form nonfunctional channels, and
they rescued the migration of cells to the cortical plate, suggesting
that the connexins’ channel function does not contribute to their
role in neuronal migration. Giardina et al. [44] demonstrate the
inﬂuence of Cx43 on resistance against H2O2-induced apoptosis
in both tumorigenic and non-tumorigenic neuronal cells in a
GJIC-independent fashion. They further showed that the glioma
cell death was blocked through the inhibition of caspase 3 activa-
tion. In primary astrocytes, siRNA knockdown of Cx43 enhanced
the toxicity of H2O2. Thus, the protective effect of Cx43 against
apoptosis is not solely found in the C6 glioma cell line, but in pri-
mary astrocytes as well. It was also shown that Cx43 protein inter-
acts directly with the ASK1 protein, an upstream activator of JNK,
from co-immunoprecipitation experiments. This is not unheard
of, since Cx43 is known to interact with other protein kinases, such
as c-Src, PKC, and ERK1/2 [10]. Therefore, the mechanism behind
Cx43 and H2O2-induced apoptosis could possibly be attributed to
the involvement of Cx43 as a signaling molecule interacting with
kinases in the ASK1 pathway. Overall, these data show that con-
nexins are involved in the directional migration of astrocytes and
neurons as well cardiac neural crest cells, supporting their essen-
tial role in development.5. Other GJIC-independent functions of connexins
Connexins have been implicated in inﬂuencing the growth,
migration, and apoptosis of various cell types involved in normal
J.Z. Zhou, J.X. Jiang / FEBS Letters 588 (2014) 1186–1192 1191differentiation and development [9,45]. Many of these studies
emphasize the channel roles of connexins on cell behavior. Dang
et al. [46] show how Cx43 inhibits DNA synthesis in Human
Embryonic Kidney 293 (HEK293) cells through the phosphoryla-
tion of its serine (S) 262 residue in response to protein kinase C
(PKC) stimulation. Because the non-channel-forming C-terminal
tail of Cx43 (Cx43CT) is able to inhibit DNA synthesis through
S262 regulation, the Cx43-mediated growth inhibition is shown
to be independent of GJIC (Fig. 2).
Connexins have been shown to inﬂuence other organs, includ-
ing the heart and lens. There are several previous studies demon-
strating the involvement of connexins in blood vessel and
cardiomyocyte generation, differentiation, and homeostasis [7].
Earlier studies identiﬁed the function of connexins in cardioprotec-
tion through its gap junction or hemichannel communication [47].
In a more recent study, Srisakuldee et al. [48] revealed a cardiopro-
tective role of phosphorylated Cx43 protein. Cx43 phosphorylated
at S262 and S368 represents a state of increased resistance to car-
diac ischemic injury, and this is upregulated by ischemic precondi-
tioning (PC), where isolated hearts were subjected to short
episodes of ischemia followed by perfusion with oxygen, or by
FGF2 treatment. These processes are shown to be dependent on
protein kinase C (PKC) activity (Fig. 2). A previous study by Li
and colleagues [49] showed that GJIC is not essential for ischemic
PC. Thus, Cx43 is likely to mediate cardioprotection through FGF2
or ischemic PC and PKC signaling in a non-GJIC manner. It was pre-
viously shown that TGF-b signaling and blood vessel cell differen-
tiation are mediated by Cx43 [50]. Dai et al. [51] examined the
involvement of Cx43 in terminally differentiated cardiomyocytes.
In this newer study, cardiomyocytes expressing endogenous Cx43
were examined, and Cx43 was shown to be involved in the regula-
tion of TGF-b signaling through microtubule-regulated Smad sig-
naling. Cx43 was revealed to compete with Smad2/3 for binding
to b-tubulin, and its interaction with Smad2/3 was found at the
microtubule level. Through the luciferase-reporter system, Cx43
was found to positively regulate TGF-b signaling. In brief, Cx43
interacts with TGF-b and regulates TGF-b/Smad signaling by trig-
gering the release of Smad2/3 and increasing the phosphorylation
of Smad2. Johnstone et al. [52] demonstrated that MAPK phosphor-
ylates Cx43 and this causes it to interact with cyclin E in vascular
smooth muscle cells (VSMC), leading to effects on proliferation
(Fig. 2). Previously, they showed that Cx43 becomes phosphory-
lated at its MAPK serine after atherogenic stimuli, which is associ-
ated with VSMC proliferation [53].
A plethora of studies have explored the role of connexins in lens
development, and mutations of these connexins have been re-
ported to lead to human congenital cataracts [54,55]. It was previ-
ously reported that the overexpression of Cx50 stimulates lens cell
differentiation [56]. In an update, Banks et al. [57] demonstrated
the important role of the C-terminus of Cx50 as a key player in lens
epithelial-ﬁber cell differentiation. Mutants of Cx50 which do not
form function gap junction channels but retain the normal expres-
sion and integrity of the Cx50 protein preserved the ability to pro-
mote lens epithelial-ﬁber cell differentiation. Additionally, the
important involvement of the Cx50 C-terminal domain in lens epi-
thelial-ﬁber cell differentiation was demonstrated by developing
C-terminus chimeric constructs in which the Cx50 and Cx46 C-ter-
mini were exchanged. As such, the Cx46 construct containing the
Cx50 C-terminus was able to stimulate lens differentiation in a
fashion similar to wild type Cx50. Thus, the authors showed for
the ﬁrst time that the C-terminal of Cx50 has a crucial role in lens
epithelial-ﬁber cell differentiation independently of GJIC. To fur-
ther investigate this, Shi et al. [58] established the structure of
the Cx50 C-terminal domain by molecular modeling, which
revealed four a-helices and a V362 residue in the middle of the
3rd helix which is functionally involved in lens epithelial-ﬁberdifferentiation and maintaining the a-helical structure. It was
shown experimentally that the stimulatory effect of Cx50 on lens
ﬁber differentiation is lessened by deletion of the PEST motif at
the C-terminus of Cx50 and a mutation of the valine 362 residue.
Additionally, mutation of V362 to charged residues disrupted the
a-helical structure. Altogether, these experiments reinforce the
signiﬁcant GJIC-independent role of Cx50 in lens cell
differentiation.6. Conclusion
It is becoming more apparent that connexins serve more pur-
poses than as mere channel proteins. They have long been known
as the components of gap junction, allowing the transfer of ions
and small signaling molecules between adjoining cells [3]. In more
recent years, its role in hemichannel formation has also been iden-
tiﬁed [1,4]. However, its non-channel functions, independent of
both gap junctions and hemichannels, are noteworthy in many
physiological processes, where the connexins proteins themselves
can directly interact with signaling molecules to affect cell behav-
ior. Likewise, this reveals the complexity of its alterations and pro-
vides many implications into its effects on a wide range of disease
types. Because of its many known roles in the cell, it is not surpris-
ing that there exists such a wide variety of different types of con-
nexins. The studies we have presented reﬂect the importance of
the connexin proteins in mediating pathways in cancer as well as
the development of organs such as the brain, the lens, and the
heart. Connexins have been shown to encompass multiple, some-
times contradictory, functions in cancer development and disease
progression [59]. There still remains a need for future studies to
examine the molecular mechanisms behind the channel-indepen-
dent role of connexins in tumor growth, migration, and cell signal-
ing, which will aid in the understanding of its many purposes in
cell physiology and pathology, and provide strategies for the treat-
ment of diseases.
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